Three Trailers In, ‘Clayface’ Still Hasn’t Shown You Clayface. That’s the Whole Strategy.

DC Studios keeps hiding Matt Hagen’s final Clayface form from us, and it appears James Watkins’ is taking a page from Spielberg on for his $40 million reimagining.

DC Studios has now released three pieces of marketing for Clayface: a teaser, a full trailer, and a final trailer that landed this week. Across all of them, you still have not seen Clayface.

You have seen a man’s face melt at a movie premiere. You have seen his eyes push out of his skull. You have seen him lock himself in an airplane bathroom and cut tendrils of skin away from his own eyes with a pair of scissors. What you have not seen, not for a single frame, is the thing Matt Hagen actually becomes. Aside from a few stills Warner Bros has released for the films marketing.

That is not an accident of editing. It is the entire marketing strategy, and the filmmakers have been open about where it comes from. They do not want to show the shark.

The Movie DC Is Not Supposed to Be Making

Clayface arrives October 23 as the strangest title on the DCU‘s Chapter One slate. It cost roughly $40 million, less than a quarter of what a Superman picture runs. It carries an R R for strong bloody violence, gore, language, some nudity and brief drug use. Its lead is a Batman villain most casual moviegoers could not pick out of a lineup.

James Watkins directs, which is the first real tell. He made The Woman in Black and Eden Lake, then remade Speak No Evil in 2024 into something meaner than the original. He is not a spectacle director. He makes audiences uncomfortable in rooms.

The script began with Mike Flanagan, who wrote the original screenplay before Hossein Amini came in for a rewrite. Flanagan builds horror out of grief, and that lineage shows in the premise. Matt Hagen is a rising movie star whose face is brutally disfigured. A scientist offers him an experimental treatment. It works, briefly, and then it does not stop working.

Tom Rhys Harries plays Hagen. Naomi Ackie plays Dr. Caitlin Corr, the scientist who hands him the thing that ruins him. Max Minghella plays Detective John Borelli, circling the wreckage. Eddie Marsan and David Dencik fill out a cast that reads like a prestige drama rather than a comic book adaptation. The production shot in Liverpool and at Warner Bros. Studios Leavesden in the fall of 2025.

What They Have Actually Shown You

The final trailer is a meaningful escalation over the first two, and it is worth being specific about why.

It shows Hagen using the transformation offensively for the first time. In one shot he presses a man’s face through his own stomach, and the victim’s features push visibly through the other side. It is the kind of image that gets a film talked about for a week.

What people have actually fixed on is his expression while he does it. There is no relish in it, no villain’s grin. He looks devastated. The trailer is arguing that Clayface is not a monster who enjoys himself, which is a much harder sell and a much better film if it works.

Harries has described the prosthetic work as so convincing that his family and friends eventually stopped reacting to his half-melted face between takes, to the point of introducing him to people over FaceTime while he was still in it.

Stealing Spielberg’s Logic

The logic comes straight from Steven Spielberg’s playbook. You do not want to show the shark. Jaws works because the animal stays offscreen while the fear compounds, and by the time you see it, the audience has built something worse in their own heads than any effects department could deliver.

Applying that to a comic book adaptation is a real risk. Superhero marketing runs on the money shot: the suit, the reveal, the silhouette. Selling a villain origin story while refusing to show the villain inverts the entire playbook, and it only pays off if the film is good enough to justify the withholding.

Harries, for his part, has confirmed the final form does arrive in the film, and described it in two words that are not printable in full. His phrasing was that it is sick. He would not say anything else about it.

So the situation heading into release is unusual. The studio has spent three rounds of marketing establishing tone, performance and dread, and has deliberately withheld the one image that would let anyone judge whether the effects work lands. Everyone is being asked to form an opinion about a body horror film without seeing the body.

Why Nobody Can Call It

Here is the problem with projecting this one.

October horror releases have a well-documented critical ceiling. Genre films that open in the Halloween corridor tend to land respectable rather than acclaimed, because the slot attracts commercial horror and critics grade against that expectation. A film has to be conspicuously better than its slot to break out of it.

Against that, DC Studios under its current leadership has been rewarded for going smaller and stranger. Funding a $40 million auteur-adjacent swing instead of another tentpole is exactly what the last two years of reviews have encouraged.

Then there is the genre problem. Body horror splits critics harder than almost anything else. The same practical effects work that earns raves in one review gets called indulgent in the next. Transformation films rarely land in the comfortable middle. They finish high or they finish poorly, with very little weight in the center.

All three pressures point in different directions, and the one piece of evidence that would settle the argument is the piece nobody outside the production has seen.

Where the Market Stands

Which is exactly why the prediction market on this film has behaved the way it has.

The question of where Clayface lands with critics has been one of the most actively traded film markets on the board, and for most of the last two months it refused to move. From the first week of August through this past Wednesday, the mid-tier threshold sat within a couple of points of a coin flip. Day after day, for roughly fifty consecutive sessions, it barely budged.

That is not normal. Markets drift as information arrives. This one sat still because no real information was arriving. The studio was showing atmosphere and withholding the evidence, and traders responded by declining to take a side.

Then the final trailer dropped, and the whole ladder moved up at once. The baseline fresh thresholds climbed, the mid-tier question broke out of its coin flip for the first time since summer, and the long-shot thresholds up near the acclaimed range posted the sharpest single-day jump in the market’s history. Money did not just get more confident. It moved up the board, on the strength of a performance rather than a monster.

The shark is still offscreen. It stays there until October 23.

You can trade the Clayface Rotten Tomatoes market on Kalshi.

SPONSORED CONTENT DISCLOSURE
This Article Is Sponsored By Kalshi, A CFTC-Regulated Prediction Market Platform. Kalshi Allows Users 18 And Older Across All 50 States To Trade On Event Outcomes Including Entertainment Markets. The Odds And Market Data Referenced In This Article Reflect Live Trading And Are Subject To Real-Time Changes. This Article Is Presented For Informational Purposes. Past Performance Of Prediction Markets Does Not Guarantee Future Results. Always Do Your Own Research Before Trading On Any Prediction Market.

Joanthan P. Moustakas

Jonathan P. Moustakas founded The Cinema Group in 2020 during the challenges of the pandemic, after losing the vital ability to find community in theaters and escape through the captivating magic of cinema. Feeling profoundly cut off from the vibrant film community he cherished, he sought to create a welcoming home for dedicated cinema fans while providing engaging, daily curated content that resonates with their passions. Years later, The Cinema Group has blossomed from a small collective of loyal fans into a thriving brand that reaches millions of audiences every month across a diverse array of platforms and mediums.

See Full Bio